Antabuse is a drug that is used to treat the symptoms of alcoholism in both males and females. This medicine is only accessible with a prescription from a doctor and is not commercially available. It is possible that your doctor will advise you to take Antabuse by itself or in conjunction with one or more additional drugs. Both possibilities are open to consideration. Antabuse was initially created in the 1950s and is considered to be a member of the class of medications called as psychiatric agents. It is more often available in pharmacies around the world under the name Disulfiram, which is the generic name for Antabuse, which is also the brand name.

Patients who suffer from persistent alcoholism may benefit from the usage of the pharmaceutical Antabuse during the management of their condition. These patients desire to continue living in environments that require them to abstain so that they may continue receiving psychotherapy and other forms of supportive care in order to improve their results.

There is no "magic bullet" treatment for alcoholism, and Antabuse is not one of them. If a medication is taken on its own and a patient with chronic alcoholism is not also provided with an appropriate incentive or supportive treatment, then there is a good chance that the medication will not have any significant impact on the patient's drinking habits. This is because the medication is not working in conjunction with any other treatment.

The initial part of the treatment consists of administering the maximum daily dosage of 500 mg in a single dose over the course of one to two weeks. This phase of the treatment is called the loading phase. Despite the fact that the standard administration time for Antabuse is in the morning, patients who experience a sedative effect from the medicine may find that taking their prescription later in the day is more beneficial. In any other circumstance, the dose might be decreased in an effort to lower the sedative effect or eliminate it entirely. This would be done in the hope of achieving one of these outcomes. The maximum daily dose of 500 milligrams must not be exceeded, and the normal maintenance dosage for everyday administration has been kept at 250 milligrams (with an equivalent range of 125 to 500 mg).

Patients who have a history of rubber contact dermatitis must first undergo testing to evaluate their level of hypersensitivity to thiuram derivatives before initiating therapy with Antabuse. This testing must be completed before the patient may start taking Antabuse. In the past, there have been reports of extremely uncommon incidences of individual persons developing liver poisoning as well as hepatic failure, which ultimately led to either transplantation or death. These cases were reported by medical professionals. Patients who are using Antabuse are cautioned to stay away from ethylene dibromide in any of its many different forms, including vapors, particularly while they are taking the medication. This is a must in order for them to receive therapy.

There has been no research conducted to evaluate whether or not Antabuse is safe for usage in pregnant individuals. Therefore, taking Antabuse while pregnant should only be done so with the permission of a qualified medical practitioner and only if the anticipated benefits are greater than the potential hazards that are linked with the medication. Taking Antabuse while pregnant should also only be done so if the expected benefits are greater than the potential hazards that are linked with the medication.